Gene Burton has more than 25 years of biotechnology industry experience, working in various roles in biotechnology company management, including recombinant drug process and product development and as well as being a seasoned recombinant protein chemist. He is currently active in biotechnology consulting for CMC phases of recombinant product development. Before taking up consulting, he was VP of Product Development and Process Sciences at Receptor BioLogix, Inc., a startup company in the oncology space working on the research and development of receptor extracellular domain-IgG fusion proteins of the HER family system of receptors. Prior to the role at Receptor BioLogix, he spent over 17 years at Genentech, Inc. and 5 years at Bayer Corporation, primarily focused on recombinant protein purification, process design , other aspects of biologics CMC activities and manufacturing implementation at scale, for pre-IND, IND and BLA drug candidates. He helped direct the purification design and small-scale production of over 50 different research proteins during his career, as well as contributing to the development of two different drug screening programs. He was instrumental in the development program of a drug candidate from its inception to completion of Phase III, acting as either project team leader, CMC team leader or its process development/manufacturing implementation manager, over the course of the project's history.